• Movie

    Click here for the video of Kyoto.

  • Important Dates:

    On-site registration
    Available for the Congress, Post-Congress Meeting, Congress Dinner, Social Event Tickets for accompanying person, Roundtable Discussion, Japanese Cultural Program and YS Night Out.

    September 23, 2017
    Deadline of e-mail application for the Roundtable Discussion.

    September 18, 2017
    Deadline of online applications for the Post-Congress Meeting, Congress Dinner, Social Event Tickets for accompanying person, Japanese Cultural Program and YS Night Out.

    September 11, 2017
    Deadline for the Local Poster Printing Service

    August 31, 2017
    Extended to September 11, 2017
    Deadline Advanced Registration

    June 30, 2017
    Extended to July 31, 2017
    Deadline Early Bird Registration

    May 21, 2017
    Deadline Late-Breaking Abstract Submission

    April 30, 2017
    Notification Abstract/Poster Presentations

    February 28, 2017
    March 14, 2017

    Deadline Abstract Submission

    December 1, 2016
    Registration Open
    Hotel Reservation Open

    October 18, 2016
    Abstract Submission Open

Educational Lecture

To get the latest update, please clear or refresh your web browser's cache.
*i.e. Google Chrome: Ctr + F5 keys

Program at a Glance

Program at a Glance

Educational Lecture

Lecture language  E = English    J = Japanese
( = Simultaneous Interpretation service is available.)

Monday, September 25

Topic1:Expanding the Role of LC-MS/MS in Therapeutic Drug Monitoring (TDM)
Topic2:TDM by LC/MS-Single analyte, multiplexing and novel drugs

Chair: Jose Castro-Perez, USA

Speakers:
 
EL-1-1
Yusuke Tanigawara (Keio University School of Medicine, Japan)
EL-1-2
Gareth Hammond (Waters Corporation, UK)

Modern targeted and untargeted LC-MS/MS screenings, and automated sample preparation system

1. Clinical Laboratory Innovation by LC-MS/MS
2. Modern targeted and untargeted LC-MS/MS screenings using low resolution systems

Chair: Akira Ishii, Japan

Speakers:
 
EL-2-1
Hikaru Shibata (Shimadzu Corporation, Japan)
EL-2-2
Franck Saint-Marcoux (Limoges University Hospital, France)

State of the Art Immunosuppressant Methodologies and Clinical Considerations

Chair: Moe Kawai, Japan

Speaker:
Randal Schneider (Abbott Laboratories, USA)

Implementation of the Toxtyper LC-MSn instrument in a routine laboratory for drug of abuse screening in urine

Chair: Markus Meyer, Germany

Speaker:
Eberhard Wieland (Institute for Clinical Chemistry and Laboratory Medicine, Laboratory at Katharinenhospital, Germany)

Precision medicine in the lung cancer

Chair: Chiyo K. Imamura, Japan

Speaker:
Hirotsugu Kenmotsu (Shizuoka Cancer Center, Japan)

Cancer immunotherapy - from basic research to clinic

Chair: Atsushi Otsuka, Japan

Speaker:
Yuka Maeda (National Cancer Center Research Institute, Japan)

Overview of the treatment strategies for patients with melanoma; focusing on the difference between Western countries and Japan

Chair: Atsushi Otsuka, Japan

Speaker:
Kenjiro Namikawa (National Cancer Center Hospital, Japan)

Tuesday, September 26

Current status of Therapeutic Drug Monitoring of immunosuppressants

Chair: Satohiro Masuda, Japan

Speaker:
Yoshihiko Watarai (Nagoya Daini Red Cross Hospital, Japan)

Current Topics for Therapeutic Drug Monitoring of Immunosuppressive Drugs
~Pharmacokinetics, Pharmacogenetics, and TDM of Immunosuppressive Drugs~

Chair: Yoshihiko Watarai, Japan

Speaker:
Shigeru Satoh (Akita University Hospital, Japan) (Simultaneous Interpretation available)

Reinforced molecular targeted therapy for Ph+ Leukemias based on risk-benefit assessment

リスク-ベネフィットを考慮したPh陽性白血病の第3世代分子標的治療

Speaker:
Arinobu Tojo (The University of Tokyo, Japan)

Pharmacokinetics/Pharmacodynamics of Lusutrombopag, a Thrombopoietin Receptor Agonist, and Prediction of Platelet Count Profile

トロンボポエチン受容体アゴニスト・ルストロンボパグのPK/PDに基づく血小板数予測

Chair: Yoshitaka Yano, Japan

Speaker:
Toshihiro Wajima (Shionogi & Co., Ltd., Japan)

The possibility of exposure response in ramucirumab therapy

Chair: Yuichi Ando, Japan

Speaker:
Toshihiko Doi (National Cancer Center Hospital East, Japan) (Simultaneous Interpretation available)

Exposure-response of erlotinib in patients with non-small cell lung cancer

Chair: Yasutsuna Sasaki, Japan

Speaker:
Chiyo K. Imamura (Keio University School of Medicine, Japan)

The Leading Edge of Therapeutic Monoclonal Antibody Monitoring:Paradigm Shift in Protein Bioanalysis by Mass Spectrometry
1.Novel monoclonal antibody bioanalysis from SHIMADZU: nano-surface and molecular-orientation limited (nSMOL) proteolysis
2.Therapeutic drug monitoring for monoclonal antibodies

Chair: Satohiro Masuda, Japan

Speakers:
 
EL-14-1
Takashi Shimada (Shimadzu Corporation, Japan)
EL-14-2
Atsushi Yonezawa (Kyoto University, Japan)

Wednesday, September 27

Educational Lecture : A to Z of Tacrolimus

Chair: Kenji Yuzawa, Japan

Speakers:
 
EL-15-1
Satohiro Masuda (Kyushu University Hospital, Japan)
EL-15-2
Atsushi Yoshizawa (Kyoto University, Japan)

Drug of abuse crisis - interactions with therapeutics-role of clinical toxicologist

Chair: Marilyn A. Huestis, USA

Speaker:
Manuela Neuman (University of Toronto, Canada)

PK/PD modeling and simulation approach to guide effective dosing strategy for antibiotic

モデル&シミュレーションを用いた抗菌薬のPK/PDと投与設計

Chair: Masato Homma, Japan

Speaker:
Toshimi Kimura (Tokyo Women's Medical University Hospital, Japan) (Simultaneous Interpretation available)

Automated Drug Monitoring exploring new accuracy frontiers
1.TDM-Immunoassay goes LC-MS/MS
2.Drugs of abuse-Automated immunoassays for forensic drug testing?

Chair: Satohiro Masuda, Japan

Speakers:
André Richter (Roche Diagnostics International AG, Switzerland)
 
Eva Hoess (Roche Diagnostics GmbH, Germany)
小野薬品工業株式会社 ブリストル・マイヤーズ スクイブ株式会社